Association of oxidative stress with realgar-induced differentiation in human leukemia HL-60 cells
- PMID: 19996592
- DOI: 10.1159/000265528
Association of oxidative stress with realgar-induced differentiation in human leukemia HL-60 cells
Abstract
Background: Realgar (arsenic sulfide, As(4)S(4)) has been shown to have clinical efficacy in patients with newly diagnosed and relapsed acute promyelocytic leukemia. Mechanistic studies have demonstrated that realgar is able to induce cell differentiation.
Methods: The oxidative stress in the realgar-induced differentiation was examined with human leukemia HL-60 cells. Cell differentiation was evaluated by the expression of cell surface antigen CD11b and nitroblue tetrazolium assay. The activities of catalase and superoxide dismutase were measured spectrophotometrically. Flow cytometry was used to assess cell cycle distribution and apoptosis, the cellular level of reactive oxygen species (ROS) and glutathione, as well as mitochondrial transmembrane potential (MTP).
Results: The realgar-induced differentiation was enhanced by hydrogen peroxide, and preceded with drastic changes in ROS and catalase, as well as small changes in superoxide dismutase and the reduced form of glutathione. MTP values at 24 h were in linear proportion to the CD11b expression at 48 h when no apoptosis was observed.
Conclusion: Oxidative stress and stress-related MTP decrease are associated with realgar-induced differentiation in HL-60 cells.
Copyright 2009 S. Karger AG, Basel.
Similar articles
-
Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by arsenic sulphide: involvement of serine/threonine protein phosphatases.Leuk Res. 2006 Nov;30(11):1399-405. doi: 10.1016/j.leukres.2006.03.016. Epub 2006 May 2. Leuk Res. 2006. PMID: 16650894
-
Realgar-induced differentiation is associated with MAPK pathways in HL-60 cells.Cell Biol Int. 2008 Dec;32(12):1497-505. doi: 10.1016/j.cellbi.2008.08.017. Epub 2008 Aug 20. Cell Biol Int. 2008. PMID: 18778786
-
Membrane-associated cytotoxicity induced by realgar in promyelocytic leukemia HL-60 cells.J Ethnopharmacol. 2006 Feb 20;103(3):366-71. doi: 10.1016/j.jep.2005.08.014. Epub 2005 Sep 19. J Ethnopharmacol. 2006. PMID: 16174554
-
The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia.J Biol Regul Homeost Agents. 1999 Oct-Dec;13(4):195-200. J Biol Regul Homeost Agents. 1999. PMID: 10703942 Review.
-
[Research progress in mineral Chinese medicine realgar].Zhongguo Zhong Yao Za Zhi. 2019 Feb;44(3):433-440. doi: 10.19540/j.cnki.cjcmm.20181121.001. Zhongguo Zhong Yao Za Zhi. 2019. PMID: 30989904 Review. Chinese.
Cited by
-
Arsenic sulfide as a potential anti‑cancer drug.Mol Med Rep. 2015 Feb;11(2):968-74. doi: 10.3892/mmr.2014.2838. Epub 2014 Nov 3. Mol Med Rep. 2015. PMID: 25371265 Free PMC article.
-
Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.Med Oncol. 2012 Jun;29(2):1328-34. doi: 10.1007/s12032-011-9848-5. Epub 2011 Feb 10. Med Oncol. 2012. PMID: 21308489
-
The critical role of redox homeostasis in shikonin-induced HL-60 cell differentiation via unique modulation of the Nrf2/ARE pathway.Oxid Med Cell Longev. 2012;2012:781516. doi: 10.1155/2012/781516. Epub 2012 Oct 15. Oxid Med Cell Longev. 2012. PMID: 23119122 Free PMC article.
-
Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview).Toxins (Basel). 2010 Jun;2(6):1568-81. doi: 10.3390/toxins2061568. Epub 2010 Jun 21. Toxins (Basel). 2010. PMID: 22069650 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials